PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17363723-0	2007	Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease.	Aldehydes	35-43	apolipoprotein B	Homo sapiens	64-84	
17363723-2	2007	The aim of this study was to evaluate the relationship between the immune response against one defined oxidized low-density lipoprotein antigen, the aldehyde-modified peptide corresponding amino acids 3136 and 3155 (MDA-p210) in apolipoprotein (apo) B-100, and progression of carotid intima media thickness (IMT).	Aldehydes	149-157	apolipoprotein B	Homo sapiens	229-255	
17363723-9	2007	CONCLUSIONS: IgM against the aldehyde-modified peptide corresponding amino acids 3136 and 3155 in apo B-100 is common in subjects with asymptomatic carotid disease, and high levels are associated with a more rapid progression of carotid IMT.	Aldehydes	29-37	apolipoprotein B	Homo sapiens	98-107